New Approaches To Neuroblastoma Therapy Consortium
Clinical trials sponsored by New Approaches To Neuroblastoma Therapy Consortium, explained in plain language.
-
Immune booster trial offers new hope for kids with Tough-to-Treat cancer
Disease control Recruiting nowThis study tests a new treatment for children and young adults with neuroblastoma that has come back or not responded to standard therapy. It combines chemotherapy drugs (temozolomide, irinotecan) with an antibody (dinutuximab) and special immune cells called NK cells from a heal…
Phase: PHASE2 • Sponsor: New Approaches to Neuroblastoma Therapy Consortium • Aim: Disease control
Last updated May 20, 2026 11:57 UTC
-
Scientists hunt for clues in neuroblastoma cells
Knowledge-focused Recruiting nowThis study collects samples of tumor tissue, blood, and bone marrow from children with high-risk neuroblastoma. Researchers will analyze these samples to learn more about how the cancer grows and how to better detect and treat it. The goal is to find ways to prevent the tumor fro…
Sponsor: New Approaches to Neuroblastoma Therapy Consortium • Aim: Knowledge-focused
Last updated May 26, 2026 11:34 UTC